ESC 365
Menu
Home
Search
Events
About
ESC Platforms
Escardio.org
ESC 365
ESC eLearning
Create an account
Sign in
Back
EHRA Premium Access
Prevalence and determinants of atrial fibrillation progression in women and men with paroxysmal atrial fibrillation - discussion.
Session:
Late Breaking Clinical Trials II - atrial fibrillation, news on ablation and sex differences
Topic:
Arrhythmias, General
Event:
EHRA 2022
Congress Presentation
Sign in for access options
7
more
presentations
in this session
Sex differences in early rhythm control therapy in atrial fibrillation
Access
Slides
Video
Sex differences in early rhythm control therapy in atrial fibrillation - discussion.
Access
Video
MANIFEST-PF: multi-national survey on methods, efficacy and safety on the post-approval clinical use of pulsed field ablation
Access
Slides
Video
MANIFEST-PF - discussion.
Access
Video
High radiofrequency power for faster and safer pulmonary vein ablation trial (POWER FAST III)
Access
Slides
Video
«
‹
1
2
›
»
Access the full session
Late Breaking Clinical Trials II - atrial fibrillation, news on ablation and sex differences
Access
Video
About the event
EHRA 2022
3 April - 5 April 2022
Sessions
Presentations
ESC 365 is supported by
Explore sponsored resources